Cytotoxic CD8+ T cells, which form the majority of tumor-infiltrating lymphocytes, are key effectors of anti-tumor immunity, which may be further subdivided into the following groups: CD8+ Tregs, Tc1, Tc2, Tc17, and Tc18 (Sierzega et al., 2017). The gene discussed is CD8A; the disease is neoplasm.